Exercise testing and exercise rehabilitation for patients with peripheral arterial disease: Status in 1997

Vascular Medicine

Volumn 2, Issue 2, 1997, Pages 147-155

  Regensteiner, Judith G ^a   Gardner, Andrew ^b   Hiatt, William R ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

Claudication; Exercise; Exercise rehabilitation; Exercise testing; Interventional therapy; Pharmacologic therapy

Indexed keywords

ARTICLE; EXERCISE TEST; FUNCTIONAL ASSESSMENT; HUMAN; INTERMITTENT CLAUDICATION; KINESIOTHERAPY; MORBIDITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REHABILITATION MEDICINE; TREADMILL EXERCISE;

EID: 0030833347     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X9700200211     Document Type: Article

References (83)

1. Kannel WB, McGee DL. Update in some epidemiologic features on intermittent claudication: the Framingham Study. J Am Geriatr Soc 1985; 33: 13-18.
2. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71: 510-15.
3. Criqui MH, Coughlm SS, Fronek A. Noninvasively diagnosed peripheral arterial disease as a predictor of mortality: results from a prospective study. Circulation 1985; 72: 768-73.
4. Criqui MH, Langer RD, Fronek A et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 12992; 326: 381-86.
5. Greenland P, Chu JS. Efficacy of cardiac rehabilitation services with emphasis on patients after myocardial infarction. Ann Intern Med 1988; 109: 650-63.
6. Lassila R, Lepantalo M, Lindfors O. Peripheral arterial disease-natural outcome. Acta Med Scand 1986; 220: 295-301.
7. McAllister FF. The fate of patients with intermittent claudication managed nonoperatively. Am J Surg 1976; 132: 593-95.
8. Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP. Review of approaches and development of recommendations for therapeutic trials. Circulation 1995; 92: 614-21.
9. Baker JD, Dix D. Variability of Doppler ankle pressures with arterial occlusive disease: An evaluation of ankle index and brachial-ankle pressure gradient. Surgery 1981; 89: 134-37.
10. Carter SA. Response of ankle systolic pressure to leg exercise in mild or questionable arterial disease. N Engl J Med 1972; 287: 578-82.
11. Strandness DE, Bell JW Jr An evaluation of the hemodynamic response of the claudicating extremity to exercise. Surg Gynecol Obstet 1964; 119: 1237-42.
12. Sumner D S., D.E. Strandness, Jr. The relationship between calf blood flow and ankle blood pressure in patients with intermittent claudication. Surgery 1969; 65: 763-71.
13. Yao ST. Haemodynamic studies in peripheral arterial disease. Br J Surg 1970; 57: 761-66.
14. Yao ST, Needham TN, Gourmoos C, Irvine WT. A comparative study of strain-guage plethysmography and Doppler ultrasound in the assessment of occlusive arterial disease of the lower extremities. Surgery 1972; 71: 4-9.
15. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation 1990; 81: 602-609.
16. Gardner AW, Skinner JS, Cantwell BW, Smith LK. Progressive vs single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc 1991; 23: 402-408.
17. Gardner AW, Skinner JS, Vaughan NR, Bryant CX, Smith LK. Comparison of three progressive exercise protocols in peripheral vascular occlusive disease. Angiology 1992; 43: 661-71.
18. Gardner AW, Skinner JS, Smith LK. Effect of handrail support on claudication and hemodynamic responses to single-stage and progressive treadmill protocols in peripheral vascular occlusive disease. Am J Cardiol 1991; 68: 99-105.
19. Hiatt WR, Nawaz D, Regensteiner JG, Hossack KF. The evaluation of exercise performance in patients with peripheral vascular disease. J Cardiopulmon Rehabil 1988; 12: 525-32.
20. Regensteiner JG, Steiner JF, Panzer RJ, Hiatt WR. Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease. J Vasc Med Biol 1990; 2: 142-52.
21. Haskell WL, Leon AS, Caspersen CJ et al. Cardiovascular benefits and assessment of physical activity and physicial fitness in adults. Med Sci Sports Exerc 1993; 24: S201-S220.
22. Whipp BJ, Davis JA, Torres T, Wasserman K. A test to determine parameters of aerobic function during exercise. J Appl Physiol 1981; 50: 217-21.
23. Regensteiner JG, Hargarten ME, Rutherford RB, Hiatt WR Functional benefits of peripheral vascular bypass surgery for patients with intermittent claudication. Angiology 1993; 44: 1-10.
24. Feinstein AR. Clinimetrics, New Haven, CT: Yale University Press, 1987.
25. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease (PAD). J Vasc Surg 1996; 23: 104-15.
26. Sallis JF, Haskell WL, Wood PD et al. Physical activity assessment methodology in the five-city project. Am J Epidemiol 1985; 121: 91-106.
27. Blair SN, Haskell WL, Paffenbarger RS, Vranizan KM, Farquhar JW, Wood PD Assessment of habitual physical activity by a seven-day recall in community survey and controlled experiments. Am J Epidemiol 1985; 122: 794-804
28. Regensteiner JG, Mayer EJ, Shetterly SM et al Relationship between physical activity and hyperinsulinemia among nondiabetic men and women. The San Luis Valley Diabetes Study. Diabetes Care 1991; 14: 1066-74.
29. Taylor CB, Coffey T, Berra K, Iaffaldano R, Casey K, Haskell WL. Seven day activity and self-report compared to a direct measure of physical activity. Am J Epidemiol 984; 120: 818-24.
30. Tarlov AR, Ware JE, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The medical outcomes study. An application of methods for monitoring the results of medical care JAMA 1989; 262: 925-30.
31. Stewart AL, Greenfield S, Hays RD et al. Functional status and wellbeing of patients with chronic conditions results from the Medical Outcomes Study. JAMA 1989; 262: 907-13
32. Brand FN, Abbott RD, Kannel WB. Diabetes, intermittent claudication, and risk of cardiovascular events. Diabetes 1989; 38: 504-509.
33. Coleridge-Smith PD, Thomas P, Scurr JH, Dormandy JA. Causes of venous ulceration, a new hypothesis. Br Med J 1988; 296: 1726-27.
34. Dormandy JA, Hoare E, Khattab AH, Arrowsmith DE, Dormandy TL. Prognostic significance of rheological and biochemical findings in patients with intermittent claudication. Br Med J 1973; 4: 581-83
35. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham Study. JAMA 1979; 241: 2035-38.
36. Pomrehn P, Duncan B, Weissfeld L et al. The association of dyslipoproteinemia with symptoms and signs of peripheral arterial disease The lipids research clinics program prevalence study. Circulation 1986; 73 (suppl I): I100-I107.
37. Taylor LM, DeFrang RD, Harris EJ, Porter JM. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. J Vasc Surg 1991; 13: 128-36.
38. Cantin B, Moorjani, S, Dagenais GR, Lupien PJ. Lipoprotein(a) distribution in a French Canadian population and its relation to intermittent claudication (The Quebec Cardiovascular Study). Am J Cardiol 1995; 75: 1224-28.
39. Quick, CRG, Cotton LT. The measured effect of stopping smoking on intermittent claudication. Br J Surg 1982; 69 (suppl) S24-S26.
40. Doubilet P, Abrams HL. The cost of underutilization. Percutaneous transluminal angioplasty for peripheral vascular disease. N Engl J Med 1984; 310: 95-102.
41. Jeans WD, Danton RM, Baird RN, Horrocks M. A comparison of the costs of vascular surgery and balloon dilatation in lower limb ischaemic disease. Br J Radiol 1986; 59: 453-56
42. Tunis SR, Bass EB, Steinberg EP. The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease. N Engl J Med 1991; 325: 556-62.
43. Thompson JE, Garrett WV. Peripheral-arterial surgery. N Engl J Med 1980; 302: 491-503.
44. Porter JM, Cutler BS, Lee BY et al. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J 1982; 104: 66-72.
45. Brevetti G, Perna S, Sabba C et al. Superiority of L-propionyl carnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study Eur Heart J 1992; 13: 251-55.
46. Brevetti G, Chiariello M, Gerulano G et al. Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine, a double-blind, cross-over study. Circulation 1988; 77: 767-73.
47. Ciostek P, Kostewicz W, Gorski G. Results of intra-aterial administration of PGE1 prostaglandin. Wiad Lek 1994; 47: 750-52.
48. Larsen OA, Lassen NA. Effect of daily muscular exercise in patients with intermittent claudication. Lance 1966; ii: 1093-96.
49. Lepantalo M, Sundberg S, Gordin A. The effects of physical training and flunarizine on walking capacity in intermittent claudication. Scand J Rehab Med 1984; 16: 159-62
50. Dahllof A, Bjorntorp P, Holm J, Schersten T. Metabolic activity of skeletal muscle in patients with peripheral arterial insufficiency. Effect of physical training. Eur J Clin Invest 1974; 4: 9-15.
51. Holm J, Dahllof A, Bjorntorp P, Schersten T. Enzyme studies in muscles of patients with intermittent claudication. Effect of training. Scand J Clin Lab Invest Suppl 1973; 128: 201-205.
52. Alpert JS, Larsen OA, Lassen NA. Exercise and intermittent claudication. Blood flow in the calf muscle during walking studied by the xenon-133 clearance method. Ciruclation 1969; 39: 353-59
53. Dahllof A, Holm J, Schersten T, Sivertsson R. Peripheral arterial insufficiency. Effect of physical training on walking tolerance, calf blood flow, and blood flow resistance. Scand J Rehab Med 1976; 8: 19-26.
54. Ericsson B, Haeger K, Lindell SE. Effect of physical training on intermittent claudication. Angiology 1970; 21: 188-92.
55. Jonason T, Ringqvist I, Oman-Rydgerg A. Home-training of patients with intermittent claudication. Scand J Rehab Med 1981; 13: 137-41.
56. Skinner JS, Strandness DE Exercise and intermittent claudication. II. Effect of physical training. Ciruclation 1967; 36: 23-29.
57. Sorlie D, Myhre K. Effects of physical training in intermittent claudication. Scand J Clin Lab Invest 1978; 38: 21722.
58. Hiatt WR, Wolfel EE, Meier RH, Regensteiner JG. Superiority of treadmill walking exercise vs strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response. Ciruclation 1994; 90: 1866-74
59. Foley WT, Wright IS. Medical management of arterial occlusion and thrombophlebitis. Mod Concepts Cardiovasc Ds 1953; 22: 162-56.
60. Ekroth R, Dahllof A, Gundevall B, Holm J, Schersten T. Physical training of patients with intermittent claudication: indications, methods, and results. Surgery 1978; 84: 640-43.
61. Zetterquist S. The effect of active training on the nutritive blood flow in exercising ischemic legs. Scand J Clin Lab Invest 1970, 25: 101-11.
62. Blumchen G, Landry F, Kiefer H and Schlosser V. Hemodynamic responses of claudicating extremities. Evaluation of a long range exercise program. Cardiology 1970; 55: 114-27.
63. Jonason T, Ringqvist I. Prediction of the effect of training on the walking tolerance in patients with intermittent claudication. Scand J Rehab Med 1987; 19: 47-50.
64. Jonason T, Ringqvist I. Effect of training on the post-exercise ankle blood pressure reaction in patients with intermittent claudication. Clin Physiol 1987; 7: 63-69.
65. Regensteiner JG, Wolfel EE, Brass EP et al. Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation 1993; 87: 413-21.
66. Mannarino E, Pasqualini L, Innocente S, Scricciolo V, Rignanese A, Ciuffetti G. Physical training and antiplatelet treatment in stage II peripheral arterial occlusive disease: alone or combined? Angiolagy 1991; 42: 513-21
67. Ernst E, Kollar L, Resch KL. Does pentoxifylline prolong the walking distance in exercise claudicants? A Placebo-controlled double-blind trial. Angiology 1992; 43: 121-25.
68. Lundgren F, Dahllof A, Lundholm K, Schersten T, Volkmann R. Intermittent claudication - surgical reconstruction or physical training? A prospective randomized trial of treatment efficiency. Ann Surg 1989; 209: 346-55
69. Creasy TS, McMillan PJ, Fletcher EWL, Collin J, Moms PJ. Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. Eur J Vasc Surg 1990; 4: 134-40.
70. Mathien GM, Terjung RL. Influence of training following bilateal stenosis of the femoral artery in rats. Am J Physiol 1986; 250: H1050-H1059.
71. Andriessen, MPHM, Barendsen GJ, Wouda AA, de Pater L. Changes of walking distance in patients with intermittent claudication during six months intensive physical training. Vasa 1989; 18: 63-68.
72. Mannarino E, Pasqualini L, Menna M, Maragoni G, Orlandi U. Effects of physical training on peripheral vascular disease: a controlled study. Angiology 1989; 40: 5-10.
73. Ernst EEW, Matrai A. Intermittent claudication, exercise, and blood rheology. Circulation 1987; 76: 1110-14.
74. Holloszy JO, Coyle EF. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 1984; 56: 831-38.
75. Jansson E, Johansson J, Sylven C, Kaijser L. Calf muscle adaptation in intermittent claudication. Side-differences in muscle metabolic characteristics in patients with unilateal arterial disease. Clin Physiol 1988; 8: 17-29.
76. Henriksson J, Nygaard E, Andersson J, Eklof B. Enzyme activities, fibre types and capillarization in calf muscles of patients with intermittent claudication. Scand J Clin Lab Invest 1980; 40: 361-69.
77. Bieber LL, Emaus R, Valkner K, Farrel S. Possible functions of short-chain and medium-chain carnitine acyltransferases. Fed Proc 1982; 41: 2858-62.
78. Brass EP, Hoppel CL. Relationship between acid-soluble carnitine and coenzyme A pools in vivo. Biochem J 1980; 190: 495-504.
79. Brass EP, Fennessey PV, Miller LV. Inhibition of oxidative metabolism by propionic acid and its reverasl by carnitine in isolated rat hepatocytesx Biochem J 1986; 236: 131-36.
80. Hiatt WR, Wolfel EE, Regensteiner JG, Brass EP. Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease. J Appl Physiol 1992; 53: 346-53.
81. England JD, Regensteiner JG, Ringel SP, Carry MR, Hiatt WR. Muscle denervation in peripheral arterial disease. Neurology 1992; 42: 994-99.
82. England JD, Hiatt WR, Ferguson M, Regensteiner JG. Progression of neuropathy in peripheral arterial disease. Muscle Nerv 1995; 18: 380-87.
83. Regensteiner JG, Hiatt WR. Benefits of exercise rehabilitation for patients with peripheral arterial disease. Exerc Sport Sci Rev 1995; 23: 1-24.